Showing results (81-90 of 112) with videos related to
Sort By:
Pageof 12
Klinicheskaia Meditsina|April 5, 2005
[Ferritin and other acute phase proteins in various forms of coronary heart disease]A D Paramonov, S V Moiseev, V V Fomin, et al.Bulletin of Experimental Biology and Medicine|January 11, 2019
Pelvic Electric Potential as a Marker of Autonomic Dysfunctions and Risk Factor of Neurogenic Arrhythmias in HumansS S Nikitin, V I Kirpatovskii, S V Moiseev, et al.Terapevticheskii Arkhiv|February 1, 2019
Cornea verticillata in Fabry diseaseS V Moiseev, D S Ismailova, A S Moiseev, et al.Terapevticheskii Arkhiv|June 2, 2015
[Clinical value of surfactant protein D as a biomarker of pulmonary fibrosis in patients with scleroderma systematica in relation to the presence of gastroesophageal reflux]A V Sosnovskaya, V V Fomin, E N Popova, et al.Terapevticheskii Arkhiv|December 6, 2022
[Modern approaches to the detection of monoclonal gammopathy of undetermined significance (MGUS) in patients with kidney diseases]L V Kozlovskaya Lysenko, N V Chebotareva, N N Mrykhin, et al.Klinicheskaia Meditsina|August 24, 2006
[Ischemic renal disease: clinical course, prognosis, possibilities of treatment]N A Mukhin, V V Fomin, S V Moiseev, et al.Terapevticheskii Arkhiv|June 30, 2020
[The long-term prospective study of patients with liver cirrhosis after elimination of the hepatitis C virus]E A Nabatchikova, D T Abdurakhmanov, E N Nikulkina, et al.Klinicheskaia Meditsina|May 7, 2016
[MORPHOGENETIC PROTEINS--FIBROBLAST GROWTH FACTOR AND KLOTHO, IN THE SERA OF PATIENTS WITH CHRONIC RENAL DISEASE]L Yu Milovanova, L V Kozlovskaya, M M Markina, et al.Terapevticheskii Arkhiv|October 26, 2022
[Organizing pneumonia as a pulmonary manifestation of post-COVID syndrome: features of diagnosis and treatment]L A Akulkina, A A Shchepalina, A A Kitbalian, et al.Terapevticheskii Arkhiv|May 17, 2019
Efficacy and safety of long-term therapy with nucleos(t)ide analogues in chronic hepatitis BE K Ibragimov, D T Abdurakhmanov, T P Rozina, et al.Pageof 12